| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $65K | -51.9% |
| Cost of Revenue | $321K | +161.0% |
| Gross Profit | -$256K | -2233.3% |
| R&D Expense | $12.3M | +11.6% |
| SG&A Expense | $7.8M | +7.4% |
| Operating Income | -$21.1M | -9.2% |
| Net Income | -$20.2M | -9.4% |
| EPS (Basic) | -$0.65 | +4.4% |
| EPS (Diluted) | -$0.65 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | -25.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $19.6M | -27.6% |
| Total Assets | $21.1M | -27.6% |
| Current Liabilities | $2.0M | -44.1% |
| Total Liabilities | $2.7M | -33.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.9M | -12.4% |
| Capital Expenditures | $49K | +250.0% |
| Investing Cash Flow | $951K | -84.4% |
| Financing Cash Flow | $7.4M | -63.9% |
| Free Cash Flow | -$14.9M | -12.6% |
| +4.4% |
| Stockholders' Equity |
| $18.4M |
| -26.7% |